A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

NCT04736758 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: GP681 tablet
DRUG: GP681 Simulant

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.